参考文献/References:
[1] Davies MJ.The pathophvsiology of acute coronary svndromes[J].Heart,2000,83(3):361-366.
[2] 张艳容.动脉粥样硬化斑块显像研究进展[J].国外医学:放射医学核医学分册,2004,28(3):109-113.
[3] Sadeghi MM,Glover DK,Lanza GM,et al.Imaging atherosclerosis and vulnerable plaque[J].J Nucl Med,2010,51(Suppl 1):51S-65.
[4] Temma T,Saji H.Radiolabelled probes for imaging of atheroscle-rotic plaques[J].Am J Nucl Med Mol Imaging,2012,2(4):432-447.
[5] Dachary-Prigent J,Freyssinet JM,Pasquet JM,et al.Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation:a flow cytometry study showing a role for free sulfhydryl groups[J].Blood,1993,81(10):2554-2565.
[6] Kolodgie FD,Petrov A,Virmani R,et al.Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V:a technique with potential for noninvasive imaging of vulnera-ble plaque[J].Circulation,2003,108(25):3134-3139.
[7] Kietselaer BL,Reutelingsperger CP,Heidendal GA,et al.Noninva-sive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis[J].N Engl J Med,2004,305(14):1472-1473.
[8] Rudd JH,Warburton EA,Fryer TD,et al.Imaging atherosclerotic plaque inflammation with[18F]-fluorodeoxyglucose positron emis-sion tomography[J].Circulation,2002,105(23):2708-2711.
[9] Wykrzykowska J,Lehman S,Williams G,et al.Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbo-hydrate,high-fat preparation[J].J Nucl Med,2009,50(4):563-568.
[10] Tahara N,Kai H,Ishibashi M,et al.Simvastatin attenuates plaque inflammation:evaluation by fluorodeoxyglucose positron emission tomography[J].J Am Coll Cardiol,2006,48(9):1825-1831.
[11] Lee SJ,On YK,Lee EJ,et al.Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction[J].J Nucl Med,2008,49(8):1277-1282.
[12] Laitinen IE,Luoto P,Nagren K,et al.Uptake of 11C-choline in mouse atherosclerotic plaques[J].J Nucl Med,2010,51(5):798-802.
[13] Kato K,Schober O,Ikeda M,et al.Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT[J].Eur J Nucl Med Mol Imag-ing,2009,36(10):1622-1628.
[14] Visse R,Nagase H.Matrix metalloproteinases and tissue inhibitorsof metalloproteinases:structure,function,and biochemistry[J].Circ Res,2003,92(8):827-839.
[15] Brown DL,Hibbs MS,Kearney M,et al.Identification of 92-kD gelatinase in human coronary atheros clerotic lesions.Association of active enzyme synthesis with unstable angina[J].Circulation,1995,91(8):2125-2131.
[16] Rajavashisth TB,Xu XP,Jovinge S,et al.Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques:evidence for activation by proinflammatory mediators[J].Circula-tion,1999,99(24):3103-3109.
[17] Ohshima S,Petrov A,Fujimoto S,et al.Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice de-ficient in apolipoprotein e or low-density-lipoprotein receptor[J].J Nucl Med,2009,50(4):612-617.
[18] Langer HF,Haubner R,Pichler BJ,et al.Radionuclide imaging:a molecular key to the atherosclerotic plaque[J].J Am Coll Cardiol,2008,52(1):1-12.
[19] Haider N,Hartung D,Fujimoto S,et al.Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclero-sis:molecular imaging facilitates understanding of pathogenesis[J].J Nucl Cardiol,2009,16(5):753-762.
[20] Ohshima S,Fujimoto S,Petrov A,et al.Effect of an antimicrobial a-gent on atherosclerotic plaques:assessment of metalloproteinase activity by molecular imaging[J].J Am Coll Cardiol,2010,55(12):1240-1249.
[21] Witztum JL,Steinberg D.Role of oxidized low density lipoprotein in atherogenesis[J].J Clin Invest,1991,88(6):1785-1792.
[22] Gerrity RG.The role of the monocyte in atherogenesis:I.Transi-tion of blood-borne monocytes into foam cells in fatty lesions[J].Am J Pathol,1981,103(2):181-190.
[23] Kugiyama K,Kerns SA,Morrisett JD,et al.Impairment of endothe-lium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins[J].Nature,1990,344(6262):160-162.
[24] Ishino S,Mukai T,Kuge Y,et al.Targeting of lectin like oxidizedlow-density lipoprotein receptor 1(LOX-1) with 99mTc-labeled anti-LOX-1 antibody:potential agent for imaging of vulnerable plaque[J].J Nucl Med,2008,49(10):1677-1685.
[25] Moons AH,Levi M,Peters RJ.Tissue factor and coronary artery dis-ease[J].Cardiovasc Res,2002,53(2):313-325.
[26] Ardissino D,Merlini PA,Bauer KA,et al.Thrombogenic potential of human coronary atherosclerotic plaques[J].Blood,2001,98(9):2726-2729.
[27] Jeanpierre E,Le Tourneau T,Six I,et al.Dietary lipid lowering modifies plaque phenotype in rabbit atheroma after angioplasty:a potential role of tissue factor[J].Clrculation,2003,108(14):1740-1745.
[28] Temma T,Ogawa Y,Kuge Y,et al.Tissue factor detection for se-lectively discriminating unstable plaques in an atherosclerotic rab-bit model[J].J Nucl Med,2010,51(12):1979-1986.
[29] Schmidt AM,Yan SD,Brett J,et al.Regulation of human mononu-clear phagocyte migration by cell surface-binding proteins for ad-vanced glycation end products[J].J Clin Invest,1993,91(5):2155-2168.
[30] Cipollone F,Iezzi A,Fazia M,et al.The receptor RAGE as a pro-gression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques:role of glycemic control[J].Circulation,2003,108(9):1070-1077.
[31] Johnson LL,Tekabe Y,Kollaros M,et al.Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs[J].EJNMMI Res,2014,4:26.
[32] Virmani R,Kolodgie FD,Burke AP,et al.Atherosclerotic plaque progression and vulnerability to rupture:angiogenesis as a source of intraplaque hemorrhage[J].Arterioscler Thromb Vasc Biol,2005,25(10):2054-2061.
[33] Antonov AS,Kolodgie FD,Munn DH,et al.Regulation of macrophage foam cell formation by αvβ3 integrin:potential role in human atherosclerosis[J].Am J Pathol,2004,165(1):247-258.
[34] Laitinen I,Saraste A,Weidl E,et al.Evaluation of αvβ3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice[J].Circ Cardiovasc Imaging,2009,2(4):331-338.
[35] Beer AJ,Pelisek J,Heider P,et al.PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis[J].JACC Cardio-vasc Imaging,2014,7(2):178-187.
[36] Motoyama S,Kondo T,Sarai M,et al.Multislice computed tomo-graphic characteristics of coronary lesions in acute coronary syn-dromes[J].J Am Coll Cardiol,2007,50(4):319-326.
[37] Huang H,Virmani R,Younis H,et al.The impact of calcification on the biomechanical stability of atherosclerotic plaques[J].Circu-lation,2001,103(8):1051-1056.
[38] Joshi NV,Vesey AT,Williams MC,et al.18F-fluoride positron emis-sion tomography for identifi cation of ruptured and high-risk coro-nary atherosclerotic plaques:a prospective clinical trial[J].Lancet,2014,383(9918):705-713.
相似文献/References:
[1]拓飞,张庆,张京,等.2014年度全国放射性核素γ能谱分析质量控制比对[J].国际放射医学核医学杂志,2015,39(5):401.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 011]
tuo fei,zhang qing,zhang jing,et al.nationwide intercomparison for radionuclide analyses through γ-spectrometry method in 2014[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):401.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 011]
[2]肖林林,金问森,张江虹,等.电离辐射诱发动脉粥样硬化的研究进展[J].国际放射医学核医学杂志,2015,39(6):493.[doi:10.3760/cma.j.issn.1673-4114.2015.06.012]
Xiao Linlin,Jin Wensen,Zhang Jianghong,et al.Research progress of radiation induced atherosclerosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):493.[doi:10.3760/cma.j.issn.1673-4114.2015.06.012]
[3]刘纯宝,兰晓莉,张永学.粥样硬化易损斑块传统影像与分子影像检测与评价现状[J].国际放射医学核医学杂志,2014,38(2):101.[doi:10.3760/cma.j.issn.1673-4114.2014.02.008]
Liu Chunbao,Lan Xiaoli,Zhang Yongxue.Current situation of detection and evaluation for atherosclerosis vulnerable plaque by conventional imaging and molecular imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):101.[doi:10.3760/cma.j.issn.1673-4114.2014.02.008]
[4]段钰,李斌,高卉,等.神经内分泌肿瘤PET/CT的应用现状与进展[J].国际放射医学核医学杂志,2013,37(3):186.[doi:10.3760/cma.j.issn.1673-4114.2013.03.014]
DUAN Yu,LI Bin,GAO Hui,et al.Application status and progress of PET/CT in neuroendocrine tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):186.[doi:10.3760/cma.j.issn.1673-4114.2013.03.014]
[5]彭武和,程静,曹庆东.核素肺通气/灌注显像在肺栓塞诊断中的现状及进展[J].国际放射医学核医学杂志,2012,36(2):80.[doi:10.3760/cma.j.issn.1673-4114.2012.02.005]
PENG Wu-he,CHENG Jing,CAO Qing-dong.Present situation and development of the nuclide lung ventilation/perfusion imaging in diagnosis of lung embolim[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):80.[doi:10.3760/cma.j.issn.1673-4114.2012.02.005]
[6]陈红红,白光.《人体体表放射性核素污染处理规范》解读[J].国际放射医学核医学杂志,2012,36(4):200.[doi:10.3760/cma.j.issn.1673-4114.2012.04.001]
CHEN Hong-hong,BAI Guang.Explanation of Specifwation of Decontamination for Radionuclides Contaminated Human Wound and Skin[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):200.[doi:10.3760/cma.j.issn.1673-4114.2012.04.001]
[7]刘庆芬,武权,樊体强,等.《放射性核素摄入量及内照射剂量估算规范》解读[J].国际放射医学核医学杂志,2012,36(4):214.[doi:10.3760/cma.j.issn.1673-4114.2012.04.005]
LIU Qing-fen,WU Quan,FAN Ti-qiang,et al.Explanation of Specification for Assessments of Intakes and Internal Doses of Radionuclides[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):214.[doi:10.3760/cma.j.issn.1673-4114.2012.04.005]
[8]张富海,孟召伟,谭建.肺癌的放射性核素分子靶向治疗[J].国际放射医学核医学杂志,2012,36(3):145.[doi:10.3760/cma.j.issn.1673-4114.2012.03.005]
ZHANG Fu-hai,MENG Zhao-wei,TAN Jian.Radionuclide molecular target therapy for lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):145.[doi:10.3760/cma.j.issn.1673-4114.2012.03.005]
[9]侯朝华,常颖欧,魏健,等.多层螺旋CT血管造影术诊断动脉粥样硬化性肾动脉狭窄的价值[J].国际放射医学核医学杂志,2011,35(5):307.[doi:10.3760/cma.j.issn.1673-4114.2011.05.013]
HOU Zhao-hua,CHANG Ying-ou,WEI Jian,et al.Evaluation of atherosclerotic renal artery stenosis by multi-slice CT angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):307.[doi:10.3760/cma.j.issn.1673-4114.2011.05.013]
[10]冯彦林,袁建伟,余丰文,等.18F-氟脱氧葡萄糖PET-CT诊断主动脉壁粥样硬化斑块的价值探讨[J].国际放射医学核医学杂志,2007,31(2):83.
FENG Yan-lin,YUAN Jian-wei,YU Feng-wen,et al.Explore the vaule of 18F-fluorodeoxyglucose PET-CT imaging in atherosclerotic plaques of aorta wall[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(1):83.